The Canadian emerging firm Aplantex Bio has established a collaboration with Symrise to create and manufacture scarce botanical molecules.
Aplantex has engineered an environmentally friendly biotechnology method relying on the ongoing generation, within a regulated setting, of plant material from exclusive photosynthetic plant replicators. This substantial biomass is then desiccated to isolate the precise molecules desired by the beauty and pharmacological sectors.
“We are fascinated by the capability of Aplantex’s cutting-edge green biotechnology technique to aid us in guaranteeing potential acquisition of difficult-to-obtain plant-derived molecules considering the considerable effects of global warming,” expressed Dr. Jakob Ley, head of Biobased Ingredients Research at Symrise.
Since 2024, Aplantex has been focusing on the initial molecule of interest for Symrise. Capitalizing on its accomplishments producing apigenin, orientin, vitexin, and luteolin—substances recognized for their antioxidant, soothing, and age-defying attributes—the firm stated it has swiftly attained numerous objectives in Symrise’s verification process.
“We are thrilled about this important business prospect, assured regarding our competence to fulfill Symrise’s outstanding objectives swiftly, and plan to furnish Symrise with extra challenging-to-procure molecules soon,” concludes Mr. Patrick Charest, B. Sc., P.Eng., mMBA, and CEO of Aplantex.
View online : www.aplantex.ca
